Tonix Pharmaceuticals Holding Corp. — Form 8-K
Filed September 22, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Tonix announced a second major managed Medicare payer agreement effective immediately, adding approximately 21 million Medicare lives (38% of ~55M total U.S. Medicare lives). This expands total Medicare coverage to 32 million lives (58%) and brings combined commercial and government payer coverage to approximately 166 million lives (53% of ~314M U.S. population). The company also activated approximately 50 new sales representatives, bringing total sales force to 150.
Why this rating
Market access expansion materially enhances TONMYA's revenue potential for company worth $271M; covers 58% of Medicare population. Real but not transformational—execution/commercialization risks remain.
Price action (we called it positive)
before filing · preread $10.79 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.